eBook: Outsourcing — Triumphs and Turmoil in Establishing Biologics CDMOs
Roger Lias
September 25, 2023
1 Min Read
Sponsored by Richter-Helm
Outsourced development and manufacturing once were all but out of the question in the biopharmaceutical industry. Regulatory changes, technical and scientific advances, and an increasingly global market have transformed a once-risky option into a common business strategy. This eBook brings a historical perspective and valuable advice from lessons learned through decades of experience. Well-known industry advocate and executive consultant Roger Lias highlights the challenges and keys to success on the service-provider side as the economic environment invites budding entrepreneurs to enter the fray.
Fill out the form below to read the full eBook now.
You May Also Like
Upcoming Webcasts
Jun 17 - Jun 20, 2024
Jun 17 - Jun 20, 2024
Our Biopharmaceutical School is the perfect course to gain a well-rounded understanding of the Biopharmaceutical industry. Over three days, you will understand the principle steps in the biopharmaceutical lifecycle, including: raw material selection, up and downstream processes and core technology. Additionally, you will be familiarised with the latest industry trends, including Industry 4.0, and how these are likely to impact the industry’s evolution.
Through a combination of sessions led by experts from the likes of GSK and Pall Biotech, as well as group discussions with your peers, you will learn how to bring a biopharmaceutical drug to market. Each day will be chaired by a different member of the BioProcess International Academy faculty and there will also be time for networking and Q&As with the experts.
Learn More
